{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:09:09Z","timestamp":1791266949148,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":122,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642335693","type":"print"},{"value":"9783642335709","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-33570-9_12","type":"book-chapter","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T12:31:22Z","timestamp":1355401882000},"page":"257-285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Progress in Cell Based Assays for Botulinum Neurotoxin Detection"],"prefix":"10.1007","author":[{"given":"Sabine","family":"Pellett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,14]]},"reference":[{"key":"12_CR1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/026119291003800401","volume":"38","author":"S Adler","year":"2010","unstructured":"Adler S, Bicker G, Bigalke H et al (2010) The current scientific and legal status of alternative methods to the LD50 test for botulinum neurotoxin potency testing. The report and recommendations of a ZEBET expert meeting. Altern Lab Anim 38:315\u2013330","journal-title":"Altern Lab Anim"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.toxicon.2010.07.015","volume":"56","author":"N Akaike","year":"2010","unstructured":"Akaike N, Ito Y, Shin MC, Nonaka K, Torii Y, Harakawa T, Ginnaga A, Kozaki S, Kaji R (2010) Effects of A2 type botulinum toxin on spontaneous miniature and evoked transmitter release from the rat spinal excitatory and inhibitory synapses. Toxicon 56:1315\u20131326","journal-title":"Toxicon"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","volume":"285","author":"SS Arnon","year":"2001","unstructured":"Arnon SS, Schechter R, Inglesby TV et al (2001) Botulinum toxin as a biological weapon: medical and public health management. JAMA 285:1059\u20131070","journal-title":"JAMA"},{"key":"12_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-5728(97)00127-6","volume":"80","author":"MG Benatar","year":"1997","unstructured":"Benatar MG, Willison HJ, Vincent A (1997) Lack of effect of Miller Fisher sera\/plasmas on transmitter release from PC12 cells. J Neuroimmunol 80:1\u20135","journal-title":"J Neuroimmunol"},{"key":"12_CR116","doi-asserted-by":"publisher","unstructured":"Bercsenyi K, Giribaldi F, Schiavo G (2012) The elusive compass of clostridial neurotoxins: deciding when and where to go? doi:10.1007\/978-3-642-33570-9_5","DOI":"10.1007\/978-3-642-33570-9_5"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF00508058","volume":"303","author":"H Bigalke","year":"1978","unstructured":"Bigalke H, Dimpfel W, Habermann E (1978) Suppression of 3H-acetylcholine release from primary nerve cell cultures by tetanus and botulinum-A toxin. Naunyn Schmiedebergs Arch Pharmacol 303:133\u2013138","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"12_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/0006-8993(85)91248-X","volume":"360","author":"H Bigalke","year":"1985","unstructured":"Bigalke H, Dreyer F, Bergey G (1985) Botulinum A neurotoxin inhibits non-cholinergic synaptic transmission in mouse spinal cord neurons in culture. Brain Res 360:318\u2013324","journal-title":"Brain Res"},{"key":"12_CR117","doi-asserted-by":"publisher","unstructured":"Binz T (2012) Clostridial neurotoxin light chains: devices for SNARE cleavage mediated blockade of neurotransmission. doi:10.1007\/978-3-642-33570-9_7","DOI":"10.1007\/978-3-642-33570-9_7"},{"key":"12_CR7","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0021-9258(17)42071-0","volume":"269","author":"T Binz","year":"1994","unstructured":"Binz T, Blasi J, Yamasaki S et al (1994) Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J Biol Chem 269:1617\u20131620","journal-title":"J Biol Chem"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/365160a0","volume":"365","author":"J Blasi","year":"1993","unstructured":"Blasi J, Chapman ER, Link E et al (1993a) Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365:160\u2013163","journal-title":"Nature"},{"key":"12_CR9","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1002\/j.1460-2075.1993.tb06171.x","volume":"12","author":"J Blasi","year":"1993","unstructured":"Blasi J, Chapman ER, Yamasaki S et al (1993b) Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1\/syntaxin. EMBO J 12:4821\u20134828","journal-title":"EMBO J"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.fsc.2006.10.001","volume":"15","author":"G Borodic","year":"2007","unstructured":"Borodic G (2007) Botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications. Facial Plast Surg Clin North Am 15:11\u201316","journal-title":"Facial Plast Surg Clin North Am"},{"key":"12_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1212\/WNL.45.1.204","volume":"45","author":"GE Borodic","year":"1995","unstructured":"Borodic GE, Duane D, Pearce B et al (1995) Antibodies to botulinum toxin. Neurology 45:204","journal-title":"Neurology"},{"key":"12_CR12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/jnr.490420510","volume":"42","author":"GJ Brewer","year":"1995","unstructured":"Brewer GJ (1995) Serum-free B27\/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J Neurosci Res 42:674\u2013683","journal-title":"J Neurosci Res"},{"key":"12_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/jnr.490350513","volume":"35","author":"GJ Brewer","year":"1993","unstructured":"Brewer GJ, Torricelli JR, Evege EK et al (1993) Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J Neurosci Res 35:567\u2013576","journal-title":"J Neurosci Res"},{"key":"12_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cps.2011.03.010","volume":"38","author":"TV Cartee","year":"2011","unstructured":"Cartee TV, Monheit GD (2011) An overview of botulinum toxins: past, present, and future. Clin Plast Surg 38:409\u2013426","journal-title":"Clin Plast Surg"},{"key":"12_CR15","doi-asserted-by":"publisher","first-page":"e8818","DOI":"10.1371\/journal.pone.0008818","volume":"5","author":"JO Conway","year":"2010","unstructured":"Conway JO, Sherwood LJ, Collazo MT et al (2010) Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents. PLoS ONE 5:e8818","journal-title":"PLoS ONE"},{"key":"12_CR16","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1002\/mds.21051","volume":"21","author":"C Cordivari","year":"2006","unstructured":"Cordivari C, Misra VP, Vincent A et al (2006) Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: the role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test. Mov Disord 21:1737\u20131741","journal-title":"Mov Disord"},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.1091\/mbc.E08-07-0765","volume":"19","author":"M Dong","year":"2008","unstructured":"Dong M, Liu H, Tepp WH et al (2008) Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol Biol Cell 19:5226\u20135237","journal-title":"Mol Biol Cell"},{"key":"12_CR18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1083\/jcb.200305098","volume":"162","author":"M Dong","year":"2003","unstructured":"Dong M, Richards DA, Goodnough MC et al (2003) Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J Cell Biol 162:1293\u20131303","journal-title":"J Cell Biol"},{"key":"12_CR19","doi-asserted-by":"publisher","first-page":"14701","DOI":"10.1073\/pnas.0404107101","volume":"101","author":"M Dong","year":"2004","unstructured":"Dong M, Tepp WH, Johnson EA et al (2004) Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells. Proc Natl Acad Sci U S A 101:14701\u201314706","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR20","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1083\/jcb.200707184","volume":"179","author":"M Dong","year":"2007","unstructured":"Dong M, Tepp WH, Liu H et al (2007) Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons. J Cell Biol 179:1511\u20131522","journal-title":"J Cell Biol"},{"key":"12_CR21","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.1123654","volume":"312","author":"M Dong","year":"2006","unstructured":"Dong M, Yeh F, Tepp WH et al (2006) SV2 is the protein receptor for botulinum neurotoxin A. Science 312:592\u2013596","journal-title":"Science"},{"key":"12_CR118","doi-asserted-by":"publisher","unstructured":"Dorner MB, Schulz KM, Kull S (2012) Complexity of botulinum neurotoxins: challenges for detection technology. doi:10.1007\/978-3-642-33570-9_11","DOI":"10.1007\/978-3-642-33570-9_11"},{"issue":"Suppl 8","key":"12_CR22","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1002\/mds.20022","volume":"19","author":"D Dressler","year":"2004","unstructured":"Dressler D (2004) Clinical presentation and management of antibody-induced failure of botulinum toxin therapy. Mov Disord 19(Suppl 8):S92\u2013S100","journal-title":"Mov Disord"},{"key":"12_CR23","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1080\/09638280701568296","volume":"29","author":"D Dressler","year":"2007","unstructured":"Dressler D, Benecke R (2007) Pharmacology of therapeutic botulinum toxin preparations. Disabil Rehabil 29:1761\u20131768","journal-title":"Disabil Rehabil"},{"key":"12_CR24","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/mds.1238","volume":"17","author":"D Dressler","year":"2002","unstructured":"Dressler D, Bigalke H (2002) Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy. Mov Disord 17:170\u2013173","journal-title":"Mov Disord"},{"key":"12_CR25","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/mds.20625","volume":"20","author":"D Dressler","year":"2005","unstructured":"Dressler D, Lange M, Bigalke H (2005) Mouse diaphragm assay for detection of antibodies against botulinum toxin type B. Mov Disord 20:1617\u20131619","journal-title":"Mov Disord"},{"issue":"Suppl 4","key":"12_CR26","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1111\/j.1524-4725.2010.01710.x","volume":"36","author":"D Dressler","year":"2010","unstructured":"Dressler D, Wohlfahrt K, Meyer-Rogge E et al (2010) Antibody-induced failure of botulinum toxin a therapy in cosmetic indications. Dermatol Surg 36(Suppl 4):2182\u20132187","journal-title":"Dermatol Surg"},{"key":"12_CR27","doi-asserted-by":"publisher","first-page":"34846","DOI":"10.1074\/jbc.M202902200","volume":"277","author":"MJ Duggan","year":"2002","unstructured":"Duggan MJ, Quinn CP, Chaddock JA et al (2002) Inhibition of release of neurotransmitters from rat dorsal root ganglia by a novel conjugate of a Clostridium botulinum toxin A endopeptidase fragment and Erythrina cristagalli lectin. J Biol Chem 277:34846\u201334852","journal-title":"J Biol Chem"},{"issue":"Suppl 8","key":"12_CR28","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1002\/mds.20010","volume":"19","author":"R Eleopra","year":"2004","unstructured":"Eleopra R, Tugnoli V, Quatrale R et al (2004) Different types of botulinum toxin in humans. Mov Disord 19(Suppl 8):S53\u2013S59","journal-title":"Mov Disord"},{"key":"12_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0304-3940(98)00775-7","volume":"256","author":"R Eleopra","year":"1998","unstructured":"Eleopra R, Tugnoli V, Rossetto O et al (1998) Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans. Neurosci Lett 256:135\u2013138","journal-title":"Neurosci Lett"},{"key":"12_CR30","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s11910-010-0129-z","volume":"10","author":"VG Evidente","year":"2010","unstructured":"Evidente VG, Adler CH (2010) An update on the neurologic applications of botulinum toxins. Curr Neurol Neurosci Rep 10:338\u2013344","journal-title":"Curr Neurol Neurosci Rep"},{"key":"12_CR119","doi-asserted-by":"publisher","unstructured":"Fischer A (2012) Synchronized chaperone function of botulinum neurotoxin domains mediates light chain translocation into neurons. doi:10.1007\/978-3-642-33570-9_6","DOI":"10.1007\/978-3-642-33570-9_6"},{"key":"12_CR31","doi-asserted-by":"publisher","first-page":"29604","DOI":"10.1074\/jbc.M703619200","volume":"282","author":"A Fischer","year":"2007","unstructured":"Fischer A, Montal M (2007a) Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes. J Biol Chem 282:29604\u201329611","journal-title":"J Biol Chem"},{"key":"12_CR32","doi-asserted-by":"publisher","first-page":"10447","DOI":"10.1073\/pnas.0700046104","volume":"104","author":"A Fischer","year":"2007","unstructured":"Fischer A, Montal M (2007b) Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes. Proc Natl Acad Sci U S A 104:10447\u201310452","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR33","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1073\/pnas.0812839106","volume":"106","author":"A Fischer","year":"2009","unstructured":"Fischer A, Nakai Y, Eubanks LM et al (2009) Bimodal modulation of the botulinum neurotoxin protein-conducting channel. Proc Natl Acad Sci U S A 106:1330\u20131335","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0733-8635(03)00070-6","volume":"22","author":"TC Flynn","year":"2004","unstructured":"Flynn TC (2004) Myobloc. Dermatol Clin 22:207\u2013211 vii","journal-title":"Dermatol Clin"},{"key":"12_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0168-1605(94)00144-U","volume":"27","author":"DF Gimenez","year":"1995","unstructured":"Gimenez DF, Gimenez JA (1995) The typing of botulinal neurotoxins. Int J Food Microbiol 27:1\u20139","journal-title":"Int J Food Microbiol"},{"key":"12_CR36","doi-asserted-by":"crossref","unstructured":"Hatheway CL (1988) Botulism. In: Balows A, Hausler WH, Ohashi M, Turano MA (eds) Laboratory diagnosis of infectious diseases: principles and practice, vol 1. Springer, New York, pp 111\u2013133","DOI":"10.1007\/978-1-4612-3898-0_12"},{"key":"12_CR120","doi-asserted-by":"publisher","unstructured":"Hill KK, Smith TJ (2012) Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. doi:10.1007\/978-3-642-33570-9_1","DOI":"10.1007\/978-3-642-33570-9_1"},{"key":"12_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-60761-691-7_8","volume":"636","author":"BY Hu","year":"2010","unstructured":"Hu BY, Zhang SC (2010) Directed differentiation of neural-stem cells and subtype-specific neurons from hESCs. Methods Mol Biol 636:123\u2013137","journal-title":"Methods Mol Biol"},{"key":"12_CR38","doi-asserted-by":"crossref","unstructured":"Johnson EA, Montecucco C (2008) Chapter 11 Botulism. In: Engel Andrew G (ed) Handbook of clinical neurology, vol 91. Elsevier, pp 333\u2013368","DOI":"10.1016\/S0072-9752(07)01511-4"},{"key":"12_CR39","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.toxicon.2006.05.007","volume":"48","author":"RG Jones","year":"2006","unstructured":"Jones RG, Alsop TA, Hull R et al (2006) Botulinum type A toxin neutralisation by specific IgG and its fragments: a comparison of mouse systemic toxicity and local flaccid paralysis assays. Toxicon 48:246\u2013254","journal-title":"Toxicon"},{"key":"12_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jpba.2010.08.013","volume":"54","author":"RG Jones","year":"2011","unstructured":"Jones RG, Liu Y, Halls C et al (2011) Release of proteolytic activity following reduction in therapeutic human serum albumin containing products: detection with a new neoepitope endopeptidase immunoassay. J Pharm Biomed Anal 54:74\u201380","journal-title":"J Pharm Biomed Anal"},{"key":"12_CR41","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1128\/AEM.01662-10","volume":"77","author":"SR Kalb","year":"2011","unstructured":"Kalb SR, Baudys J, Egan C et al (2011) Different substrate recognition requirements for cleavage of synaptobrevin-2 by Clostridium baratii and Clostridium botulinum type F neurotoxins. Appl Environ Microbiol 77:1301\u20131308","journal-title":"Appl Environ Microbiol"},{"key":"12_CR42","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1021\/bi0356698","volume":"43","author":"JE Keller","year":"2004","unstructured":"Keller JE, Cai F, Neale EA (2004) Uptake of botulinum neurotoxin into cultured neurons. Biochemistry 43:526\u2013532","journal-title":"Biochemistry"},{"key":"12_CR43","doi-asserted-by":"publisher","first-page":"13476","DOI":"10.1074\/jbc.M010992200","volume":"276","author":"JE Keller","year":"2001","unstructured":"Keller JE, Neale EA (2001) The role of the synaptic protein snap-25 in the potency of botulinum neurotoxin type A. J Biol Chem 276:13476\u201313482","journal-title":"J Biol Chem"},{"key":"12_CR44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0014-5793(99)00948-5","volume":"456","author":"JE Keller","year":"1999","unstructured":"Keller JE, Neale EA, Oyler G et al (1999) Persistence of botulinum neurotoxin action in cultured spinal cord cells. FEBS Lett 456:137\u2013142","journal-title":"FEBS Lett"},{"key":"12_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/mds.870120116","volume":"12","author":"KR Kessler","year":"1997","unstructured":"Kessler KR, Benecke R (1997) The EBD test\u2013a clinical test for the detection of antibodies to botulinum toxin type A. Mov Disord 12:95\u201399","journal-title":"Mov Disord"},{"key":"12_CR46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.scr.2011.01.002","volume":"6","author":"E Kiris","year":"2011","unstructured":"Kiris E, Nuss JE, Burnett JC et al (2011) Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery. Stem Cell Res 6:195\u2013205","journal-title":"Stem Cell Res"},{"key":"12_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1385-299X(00)00037-4","volume":"6","author":"BM Kivell","year":"2001","unstructured":"Kivell BM, McDonald FJ, Miller JH (2001) Method for serum-free culture of late fetal and early postnatal rat brainstem neurons. Brain Res Brain Res Protoc 6:91\u201399","journal-title":"Brain Res Brain Res Protoc"},{"key":"12_CR48","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jcp.20394","volume":"205","author":"K Kohno","year":"2005","unstructured":"Kohno K, Kawakami T, Hiruma H (2005) Effects of soluble laminin on organelle transport and neurite growth in cultured mouse dorsal root ganglion neurons: difference between primary neurites and branches. J Cell Physiol 205:253\u2013261","journal-title":"J Cell Physiol"},{"key":"12_CR49","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/2338","volume":"5","author":"DB Lacy","year":"1998","unstructured":"Lacy DB, Tepp W, Cohen AC et al (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 5:898\u2013902","journal-title":"Nat Struct Biol"},{"key":"12_CR50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1504\/TBJ.2008.018955","volume":"1","author":"JO Lee","year":"2008","unstructured":"Lee JO, Rosenfield J, Tzipori S et al (2008) M17 human neuroblastoma cell as a cell model for investigation of botulinum neurotoxin A activity and evaluation of BoNT\/A specific antibody. The Botulinum J 1:135\u2013152","journal-title":"The Botulinum J"},{"key":"12_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ab.2012.02.038","volume":"425","author":"YY Liu","year":"2012","unstructured":"Liu YY, Rigsby P, Sesardic D et al (2012) A functional dual-coated (FDC) microtitre plate method to replace the botulinum toxin LD (50) test. Anal Biochem 425:28\u201335","journal-title":"Anal Biochem"},{"key":"12_CR52","doi-asserted-by":"publisher","first-page":"8625","DOI":"10.1128\/AEM.05155-11","volume":"77","author":"TE Macdonald","year":"2011","unstructured":"Macdonald TE, Helma CH, Shou Y et al (2011) Analysis of Clostridium botulinum serotype E strains by using multilocus sequence typing, amplified fragment length polymorphism, variable-number tandem-repeat analysis, and botulinum neurotoxin gene sequencing. Appl Environ Microbiol 77:8625\u20138634","journal-title":"Appl Environ Microbiol"},{"key":"12_CR53","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0014-5793(90)80582-4","volume":"261","author":"C McInnes","year":"1990","unstructured":"McInnes C, Dolly JO (1990) Ca2(+)-dependent noradrenaline release from permeabilised PC12 cells is blocked by botulinum neurotoxin A or its light chain. FEBS Lett 261:323\u2013326","journal-title":"FEBS Lett"},{"key":"12_CR54","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1471-4159.1991.tb02566.x","volume":"56","author":"HT McMahon","year":"1991","unstructured":"McMahon HT, Nicholls DG (1991) Transmitter glutamate release from isolated nerve terminals: evidence for biphasic release and triggering by localized Ca2+. J Neurochem 56:86\u201394","journal-title":"J Neurochem"},{"key":"12_CR55","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbrc.2010.12.132","volume":"405","author":"P McNutt","year":"2011","unstructured":"McNutt P, Celver J, Hamilton T et al (2011) Embryonic stem cell-derived neurons are a novel, highly sensitive tissue culture platform for botulinum research. Biochem Biophys Res Commun 405:85\u201390","journal-title":"Biochem Biophys Res Commun"},{"key":"12_CR56","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","volume":"79","author":"M Montal","year":"2010","unstructured":"Montal M (2010) Botulinum neurotoxin: a marvel of protein design. Annu Rev Biochem 79:591\u2013617","journal-title":"Annu Rev Biochem"},{"key":"12_CR57","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/0968-0004(86)90282-3","volume":"11","author":"C Montecucco","year":"1986","unstructured":"Montecucco C (1986) How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem Sci 11:314\u2013317","journal-title":"Trends Biochem Sci"},{"key":"12_CR58","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00702-009-0223-z","volume":"116","author":"K Muller","year":"2009","unstructured":"Muller K, Mix E, Adib Saberi F et al (2009) Prevalence of neutralising antibodies in patients treated with botulinum toxin type A for spasticity. J Neural Transm 116:579\u2013585","journal-title":"J Neural Transm"},{"key":"12_CR59","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1016\/S0021-9258(17)34087-5","volume":"269","author":"T Nishiki","year":"1994","unstructured":"Nishiki T, Kamata Y, Nemoto Y et al (1994) Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J Biol Chem 269:10498\u201310503","journal-title":"J Biol Chem"},{"key":"12_CR60","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1087057109354779","volume":"15","author":"JE Nuss","year":"2010","unstructured":"Nuss JE, Ruthel G, Tressler LE et al (2010) Development of cell-based assays to measure botulinum neurotoxin serotype A activity using cleavage-sensitive antibodies. J Biomol Screen 15:42\u201351","journal-title":"J Biomol Screen"},{"key":"12_CR61","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/0736-5748(95)00052-6","volume":"13","author":"D Parnas","year":"1995","unstructured":"Parnas D, Linial M (1995) Cholinergic properties of neurons differentiated from an embryonal carcinoma cell-line (P19). Int J Dev Neurosci 13:767\u2013781","journal-title":"Int J Dev Neurosci"},{"issue":"183\u2013265","key":"12_CR62","first-page":"320","volume":"55","author":"MW Peck","year":"2009","unstructured":"Peck MW (2009) Biology and genomic analysis of Clostridium botulinum. Adv Microb Physiol 55(183\u2013265):320","journal-title":"Adv Microb Physiol"},{"key":"12_CR63","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.bbrc.2010.11.128","volume":"404","author":"S Pellett","year":"2011","unstructured":"Pellett S, Du ZW, Pier CL et al (2011) Sensitive and quantitative detection of botulinum neurotoxin in neurons derived from mouse embryonic stem cells. Biochem Biophys Res Commun 404:388\u2013392","journal-title":"Biochem Biophys Res Commun"},{"key":"12_CR64","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1016\/j.febslet.2007.08.078","volume":"581","author":"S Pellett","year":"2007","unstructured":"Pellett S, Tepp WH, Clancy CM et al (2007) A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies. FEBS Lett 581:4803\u20134808","journal-title":"FEBS Lett"},{"key":"12_CR65","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.vascn.2010.01.003","volume":"61","author":"S Pellett","year":"2010","unstructured":"Pellett S, Tepp WH, Toth SI et al (2010) Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination. J Pharmacol Toxicol Methods 61:304\u2013310","journal-title":"J Pharmacol Toxicol Methods"},{"key":"12_CR66","doi-asserted-by":"crossref","unstructured":"Peng L, Berntsson RP, Tepp WH et al. (2012) Botulinum neurotoxin D-C uses synaptotagmin I\/II as receptors and human synaptotagmin II is not an effective receptor for type B, D-C, and G toxins. J Cell Sci. March 2012 epub ahead of print","DOI":"10.1242\/jcs.103564"},{"key":"12_CR67","doi-asserted-by":"publisher","first-page":"e1002008","DOI":"10.1371\/journal.ppat.1002008","volume":"7","author":"L Peng","year":"2011","unstructured":"Peng L, Tepp WH, Johnson EA et al (2011) Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors. PLoS Pathog 7:e1002008","journal-title":"PLoS Pathog"},{"key":"12_CR68","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/toxins3010063","volume":"3","author":"A Pickett","year":"2011","unstructured":"Pickett A, Perrow K (2011) Towards new uses of botulinum toxin as a novel therapeutic tool. Toxins (Basel) 3:63\u201381","journal-title":"Toxins (Basel)"},{"key":"12_CR69","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.febslet.2010.11.045","volume":"585","author":"CL Pier","year":"2011","unstructured":"Pier CL, Chen C, Tepp WH et al (2011) Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1. FEBS Lett 585:199\u2013206","journal-title":"FEBS Lett"},{"key":"12_CR70","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0161-813X(01)00042-0","volume":"22","author":"JR Purkiss","year":"2001","unstructured":"Purkiss JR, Friis LM, Doward S et al (2001) Clostridium botulinum neurotoxins act with a wide range of potencies on SH-SY5Y human neuroblastoma cells. Neurotoxicology 22:447\u2013453","journal-title":"Neurotoxicology"},{"key":"12_CR71","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1128\/AEM.03109-09","volume":"76","author":"BH Raphael","year":"2010","unstructured":"Raphael BH, Choudoir MJ, Luquez C et al (2010) Sequence diversity of genes encoding botulinum neurotoxin type F. Appl Environ Microbiol 76:4805\u20134812","journal-title":"Appl Environ Microbiol"},{"key":"12_CR72","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.toxicon.2009.01.019","volume":"53","author":"C Rasetti-Escargueil","year":"2009","unstructured":"Rasetti-Escargueil C, Jones RG, Liu Y, Sesardic D (2009) Measurement of botulinum types A, B and E neurotoxicity using the phrenic nerve-hemidiaphragm: improved precision with in-bred mice. Toxicon 53:503\u2013511","journal-title":"Toxicon"},{"key":"12_CR73","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1504\/TBJ.2011.041814","volume":"2","author":"C Rasetti-Escargueil","year":"2011","unstructured":"Rasetti-Escargueil C, Machado CB, Preneta-Blanc R et al (2011a) Enhanced sensitivity to botulinum type A neurotoxin of human neuroblastoma SH-SY5Y cells after differentiation into mature neuronal cells. The Botulinum J 2:30\u201348","journal-title":"The Botulinum J"},{"key":"12_CR74","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.toxicon.2011.04.003","volume":"57","author":"C Rasetti-Escargueil","year":"2011","unstructured":"Rasetti-Escargueil C, Liu Y, Rigsby P et al (2011b) Phrenic nerve-hemidiaphragm as a highly sensitive replacement assay for determination of functional botulinum toxin antibodies. Toxicon 57:1008\u20131016","journal-title":"Toxicon"},{"key":"12_CR75","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1471-4159.2006.03884.x","volume":"98","author":"A Ravni","year":"2006","unstructured":"Ravni A, Bourgault S, Lebon A et al (2006) The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways. J Neurochem 98:321\u2013329","journal-title":"J Neurochem"},{"key":"12_CR76","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/BF02639379","volume":"29A","author":"P Ray","year":"1993","unstructured":"Ray P (1993) Botulinum toxin A inhibits acetylcholine release from cultured neurons in vitro. In Vitro Cell Dev Biol Anim 29A:456\u2013460","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"12_CR121","doi-asserted-by":"publisher","unstructured":"Rummel A (2012) Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. doi:10.1007\/978-3-642-33570-9_4","DOI":"10.1007\/978-3-642-33570-9_4"},{"key":"12_CR77","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1111\/j.1471-4159.2009.06298.x","volume":"110","author":"A Rummel","year":"2009","unstructured":"Rummel A, Hafner K, Mahrhold S et al (2009) Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor. J Neurochem 110:1942\u20131954","journal-title":"J Neurochem"},{"key":"12_CR78","doi-asserted-by":"publisher","first-page":"30865","DOI":"10.1074\/jbc.M403945200","volume":"279","author":"A Rummel","year":"2004","unstructured":"Rummel A, Karnath T, Henke T et al (2004) Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J Biol Chem 279:30865\u201330870","journal-title":"J Biol Chem"},{"key":"12_CR79","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1111\/j.1742-4658.2011.08196.x","volume":"278","author":"A Rummel","year":"2011","unstructured":"Rummel A, Mahrhold S, Bigalke H et al (2011) Exchange of the H (CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin. FEBS J 278:4506\u20134515","journal-title":"FEBS J"},{"key":"12_CR80","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neuroscience.2012.03.001","volume":"210","author":"RA Saadi","year":"2012","unstructured":"Saadi RA, He K, Hartnett KA et al (2012) SNARE-dependent upregulation of potassium chloride co-transporter 2 activity after metabotropic zinc receptor activation in rat cortical neurons in vitro. Neuroscience 210:38\u201346","journal-title":"Neuroscience"},{"key":"12_CR81","first-page":"96","volume":"61","author":"EJ Schantz","year":"1978","unstructured":"Schantz EJ, Kautter DA (1978) Standardized assay for Clostridium botulinum toxins. J Assoc Official Anal Chem 61:96\u201399","journal-title":"J Assoc Official Anal Chem"},{"key":"12_CR82","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/mr.56.1.80-99.1992","volume":"56","author":"EJ Schantz","year":"1992","unstructured":"Schantz EJ, Johnson EA (1992) Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev 56:80\u201399","journal-title":"Microbiol Rev"},{"key":"12_CR83","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/359832a0","volume":"359","author":"G Schiavo","year":"1992","unstructured":"Schiavo G, Benfenati F, Poulain B et al (1992) Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359:832\u2013835","journal-title":"Nature"},{"key":"12_CR84","doi-asserted-by":"crossref","first-page":"20213","DOI":"10.1016\/S0021-9258(17)31976-2","volume":"269","author":"G Schiavo","year":"1994","unstructured":"Schiavo G, Malizio C, Trimble WS et al (1994) Botulinum G neurotoxin cleaves VAMP\/synaptobrevin at a single Ala\u2013Ala peptide bond. J Biol Chem 269:20213\u201320216","journal-title":"J Biol Chem"},{"key":"12_CR85","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","volume":"80","author":"G Schiavo","year":"2000","unstructured":"Schiavo G, Matteoli M, Montecucco C (2000) Neurotoxins affecting neuroexocytosis. Physiol Rev 80:717\u2013766","journal-title":"Physiol Rev"},{"key":"12_CR86","doi-asserted-by":"publisher","first-page":"10566","DOI":"10.1074\/jbc.270.18.10566","volume":"270","author":"G Schiavo","year":"1995","unstructured":"Schiavo G, Shone CC, Bennett MK et al (1995) Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J Biol Chem 270:10566\u201310570","journal-title":"J Biol Chem"},{"key":"12_CR87","doi-asserted-by":"crossref","first-page":"11516","DOI":"10.1016\/S0021-9258(19)50230-7","volume":"268","author":"G Schiavo","year":"1993","unstructured":"Schiavo G, Shone CC, Rossetto O et al (1993) Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP\/synaptobrevin. J Biol Chem 268:11516\u201311519","journal-title":"J Biol Chem"},{"issue":"(Suppl 8)","key":"12_CR133","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1002\/mds.20021","volume":"19","author":"D Sesardic","year":"2004","unstructured":"Sesardic D, Jones RG, Leung T et al (2004) Detection of antibodies against botulinum toxins.  Mov Disord 19(Suppl 8):S85\u2013S91","journal-title":"Mov Disord"},{"key":"12_CR88","first-page":"581","volume":"14","author":"D Sesardic","year":"2007","unstructured":"Sesardic D, Das RG (2007) Alternatives to the LD50 assay for botulinum toxin potency testing: strategies and progress towards refinement, reduction and replacement. Special Issue 14:581\u2013585","journal-title":"Special Issue"},{"key":"12_CR89","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.biologicals.2003.08.001","volume":"31","author":"D Sesardic","year":"2003","unstructured":"Sesardic D, Leung T, Gaines Das R (2003) Role for standards in assays of botulinum toxins: international collaborative study of three preparations of botulinum type A toxin. Biologicals 31:265\u2013276","journal-title":"Biologicals"},{"key":"12_CR90","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.toxicon.2004.11.009","volume":"45","author":"RE Sheridan","year":"2005","unstructured":"Sheridan RE, Smith TJ, Adler M (2005) Primary cell culture for evaluation of botulinum neurotoxin antagonists. Toxicon 45:377\u2013382","journal-title":"Toxicon"},{"key":"12_CR91","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/j.1432-1033.1992.tb17137.x","volume":"207","author":"CC Shone","year":"1992","unstructured":"Shone CC, Melling J (1992) Inhibition of calcium-dependent release of noradrenaline from PC12 cells by botulinum type-A neurotoxin. Long-term effects of the neurotoxin on intact cells. Eur J Biochem 207:1009\u20131016","journal-title":"Eur J Biochem"},{"key":"12_CR92","doi-asserted-by":"publisher","first-page":"5450","DOI":"10.1128\/IAI.73.9.5450-5457.2005","volume":"73","author":"TJ Smith","year":"2005","unstructured":"Smith TJ, Lou J, Geren IN et al (2005) Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun 73:5450\u20135457","journal-title":"Infect Immun"},{"key":"12_CR93","unstructured":"Solomon HM, Lilly T (2001) Clostridium botulinum. In: BAM bacteriological analytical manual U.S. Food and Drug Administration, Chapter 17, 8th edn. Revision A"},{"key":"12_CR94","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1177\/1087057106299163","volume":"12","author":"AM Stahl","year":"2007","unstructured":"Stahl AM, Ruthel G, Torres-Melendez E et al (2007) Primary cultures of embryonic chicken neurons for sensitive cell-based assay of botulinum neurotoxin: implications for therapeutic discovery. J Biomol Screen 12:370\u2013377","journal-title":"J Biomol Screen"},{"key":"12_CR95","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.febslet.2011.12.037","volume":"586","author":"J Strotmeier","year":"2012","unstructured":"Strotmeier J, Willjes G, Binz T et al (2012) Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: increased therapeutic dosage and immunogenicity. FEBS Lett 586:310\u2013313","journal-title":"FEBS Lett"},{"key":"12_CR96","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1111\/j.1742-4658.2011.08183.x","volume":"278","author":"S Swaminathan","year":"2011","unstructured":"Swaminathan S (2011) Molecular structures and functional relationships in clostridial neurotoxins. FEBS J 278:4467\u20134485","journal-title":"FEBS J"},{"key":"12_CR97","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861\u2013872","journal-title":"Cell"},{"key":"12_CR98","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10571-012-9818-2","volume":"32","author":"MA Tegenge","year":"2012","unstructured":"Tegenge MA, Bohnel H, Gessler F et al (2012) Neurotransmitter vesicle release from human model neurons (NT2) is sensitive to botulinum toxin A. Cell Mol Neurobiol 32:1021\u20131029","journal-title":"Cell Mol Neurobiol"},{"key":"12_CR99","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.2174\/138161209789271843","volume":"15","author":"DD Truong","year":"2009","unstructured":"Truong DD, Stenner A, Reichel G (2009) Current clinical applications of botulinum toxin. Curr Pharm Des 15:3671\u20133680","journal-title":"Curr Pharm Des"},{"key":"12_CR100","doi-asserted-by":"crossref","unstructured":"Tsukamoto K, Arimitsu H, Ochi S et al. (2012) P19 embryonal carcinoma cells exhibit high sensitivity to botulinum type C and D\/C mosaic neurotoxins. Microbiol Immunol July 2012 epub ahead of print","DOI":"10.1111\/j.1348-0421.2012.00490.x"},{"key":"12_CR101","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/jnr.22223","volume":"88","author":"M Uemura","year":"2010","unstructured":"Uemura M, Refaat MM, Shinoyama M et al (2010) Matrigel supports survival and neuronal differentiation of grafted embryonic stem cell-derived neural precursor cells. J Neurosci Res 88:542\u2013551","journal-title":"J Neurosci Res"},{"key":"12_CR102","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/0896-6273(94)90415-4","volume":"13","author":"B Ullrich","year":"1994","unstructured":"Ullrich B, Li C, Zhang JZ, McMahon H et al (1994) Functional properties of multiple synaptotagmins in brain. Neuron 13:1281\u20131291","journal-title":"Neuron"},{"key":"12_CR103","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1600-0854.2006.00520.x","volume":"8","author":"C Verderio","year":"2007","unstructured":"Verderio C, Grumelli C, Raiteri L et al (2007) Traffic of botulinum toxins A and E in excitatory and inhibitory neurons. Traffic 8:142\u2013153","journal-title":"Traffic"},{"key":"12_CR104","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","volume":"38","author":"MJ Welch","year":"2000","unstructured":"Welch MJ, Purkiss JR, Foster KA (2000) Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 38:245\u2013258","journal-title":"Toxicon"},{"key":"12_CR105","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/toxsci\/kfr354","volume":"126","author":"RC Whitemarsh","year":"2012","unstructured":"Whitemarsh RC, Strathman MJ, Chase LG et al (2012) Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection. Toxicol Sci 126:426\u2013435","journal-title":"Toxicol Sci"},{"key":"12_CR106","doi-asserted-by":"crossref","unstructured":"Wichterle H, Peljto M (2008) Differentiation of mouse embryonic stem cells to spinal motor neurons. Curr Protoc Stem Cell Biol Chapter 1: Unit 1H.1.1\u20131H.1.9","DOI":"10.1002\/9780470151808.sc01h01s5"},{"key":"12_CR107","first-page":"235","volume":"61","author":"TD Wilder-Kofie","year":"2011","unstructured":"Wilder-Kofie TD, Luquez C, Adler M et al (2011) An alternative in vivo method to refine the mouse bioassay for botulinum toxin detection. Comp Med 61:235\u2013242","journal-title":"Comp Med"},{"key":"12_CR108","doi-asserted-by":"publisher","first-page":"7694","DOI":"10.1074\/jbc.271.23.13549","volume":"271","author":"LC Williamson","year":"1996","unstructured":"Williamson LC, Halpern JL, Montecucco C et al (1996) Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25\u00a0kDa. J Biol Chem 271:7694\u20137699","journal-title":"J Biol Chem"},{"key":"12_CR109","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0891-5849(99)00268-3","volume":"28","author":"C Xie","year":"2000","unstructured":"Xie C, Markesbery WR, Lovell MA (2000) Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium. Free Radic Biol Med 28:665\u2013672","journal-title":"Free Radic Biol Med"},{"key":"12_CR110","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jcp.22231","volume":"225","author":"T Yaguchi","year":"2010","unstructured":"Yaguchi T, Nishizaki T (2010) Extracellular high K+ stimulates vesicular glutamate release from astrocytes by activating voltage-dependent calcium channels. J Cell Physiol 225:512\u2013518","journal-title":"J Cell Physiol"},{"key":"12_CR111","doi-asserted-by":"crossref","first-page":"12764","DOI":"10.1016\/S0021-9258(18)99941-2","volume":"269","author":"S Yamasaki","year":"1994","unstructured":"Yamasaki S, Baumeister A, Binz T et al (1994) Cleavage of members of the synaptobrevin\/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. J Biol Chem 269:12764\u201312772","journal-title":"J Biol Chem"},{"key":"12_CR112","doi-asserted-by":"publisher","first-page":"32815","DOI":"10.1074\/jbc.M205258200","volume":"277","author":"BC Yowler","year":"2002","unstructured":"Yowler BC, Kensinger RD, Schengrund CL (2002) Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I. J Biol Chem 277:32815\u201332819","journal-title":"J Biol Chem"},{"key":"12_CR113","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917\u20131920","journal-title":"Science"},{"key":"12_CR114","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1750-3639.2006.00008.x","volume":"16","author":"SC Zhang","year":"2006","unstructured":"Zhang SC (2006) Neural subtype specification from embryonic stem cells. Brain Pathol 16:132\u2013142","journal-title":"Brain Pathol"},{"key":"12_CR115","unstructured":"Zhu H, Wang J, Jacky BPS et al (2010) Cells useful for immuno-based botulinum toxin serotype A activity assays. US-Patent 12\/722801 (Allergan Inc) CA, USA"}],"container-title":["Current Topics in Microbiology and Immunology","Botulinum Neurotoxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-33570-9_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T10:05:03Z","timestamp":1710497103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-33570-9_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642335693","9783642335709"],"references-count":122,"aliases":["10.1007\/978-3-662-45790-0_12"],"URL":"https:\/\/doi.org\/10.1007\/978-3-642-33570-9_12","relation":{},"ISSN":["0070-217X"],"issn-type":[{"value":"0070-217X","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"14 December 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}